Pfizer (PFE) is today’s 360 round stock. Vamil Divan, Senior Biopharmaceuticals Research Analyst at Mizuho Americas, and Nathan Peterson, Director of Derivatives Analysis at Schwab Center for Financial Research discuss how the Covid-19 vaccine booster shot is approved by the FDA and CDC for use in all adults. They talk about how Mizuho has a neutral rating on PFE. They then go over how PFE and BioNTech (BNTX) data shows how the Covid-19 vaccine is effective in kids 12 to 15. Tune in to find out more.
Trading 360
22 Nov 2021
SHARE
Morning Trade Live
07 Nov 2022
Market On Close
23 Oct 2022
Futures
04 Nov 2022
Market On Close
10 Nov 2022
Market On Close
03 Oct 2022
Market On Close
15 Sep 2022